Columbia Care Completes Acquisition of Green Leaf Medical; Cements Market Leading Position in Mid-Atlantic

/in /by

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of medical and adult-use cannabis products in the United States, today announced that it has completed its acquisition of Green Leaf Medical, LLC (“Green Leaf” or “gLeaf”), a privately held, fully-integrated cannabis multi-state operator (MSO) with a leading market presence throughout the mid-Atlantic region. Total upfront consideration was approximately $240 million.

Premier Information Management, Inc. Announces Reverse Merger with Cannabinoid Biosciences, Inc.

/in /by

Premier Information Management, Inc. (OTC: PIFR) announced Thursday that it has entered into a reverse merger agreement with Cannabinoid Biosciences, Inc. a California biopharmaceutical company, which intends to engage in the discovery, development, and commercialization of cures and novel therapeutics from proprietary cannabinoid, cannabidiol, endocannabinoids, phytocannabinoids, and synthetic cannabinoids product platform suitable for specific treatments in a broad range of disease areas.

Marijuana MSO TerrAscend Buys Pennsylvania Dispensaries for $63M

/in /by

North American cannabis operator TerrAscend is doubling its Pennsylvania footprint with the acquisition of three additional retail outlets for $63 million. TerrAscend, which has offices in Toronto and New York, signed a definitive agreement to acquire the remaining 90% of KCR Holdings, which operates the medical marijuana dispensaries in northeast Pennsylvania under the name Keystone Canna Remedies. TerrAscend already owned 10% of KCR. Counting that 10% stake, the three dispensaries are valued at $70 million.

Jushi Holdings Inc. to Acquire Licensed Cultivator in Ohio

/in /by

Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF), a vertically integrated, multi-state cannabis operator, announced it has signed a definitive binding agreement to acquire OhiGrow, LLC, one of 34 licensed cultivators in Ohio, and Ohio Green Grow LLC (collectively, “OhiGrow”), for total consideration of $5.0 million in cash, inclusive of an approximately 10,000 sq. ft. facility and 1.35 acres of land (the “Acquisition”). OhiGrow will complement the soon-to-be operational 8,000 sq. ft. state-of-the-art Ohio medical cannabis processing facility (“Processing Facility”), to which Jushi provides operational and consulting services.

Neon Bloom, Inc. Announces Acquisition of Bazelet Health Systems, Inc.

/in /by

Neon Bloom, Inc. (OTC: NBCO), is proud to announce it has closed on the acquisition of Bazelet Health Systems, Inc. This acquisition was an all-stock purchase of 120,000,000 Neon Bloom, Inc. common shares for 100% of the outstanding shares of Bazelet Health Systems, Inc. “Bazelet Corporation has the remarkable opportunity to lead the scientific expansion and commercialization of THC Free cannabis, further revolutionizing the field of genome engineering and sequencing.” Said Michael Clinton, Bazelet co-founder.

Harvest Health & Recreation Inc. Announces Divestiture of North Dakota Assets

/in /by

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., has completed the divestiture of its dispensary assets in North Dakota. A local operator acquired Harvest’s two medical marijuana dispensaries located in Bismarck and Williston, North Dakota.

Cresco Labs Closes Acquisition of Verdant Creations’ Four Dispensaries

/in /by

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated, multistate cannabis operators in the United States, announced today the closing of its acquisition of Verdant Creations dispensaries in Cincinnati, Chillicothe, Newark and Marion, Ohio (collectively “Verdant”). These acquisitions give Cresco four additional dispensaries, bringing the Company’s dispensary presence in Ohio to five – the maximum allowed by the state.

Columbia Care Signs Definitive Agreement to Acquire Green Leaf Medical

/in /by

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) has signed a definitive agreement to acquire Green Leaf Medical, LLC (“Green Leaf”), a privately held, fully-integrated cannabis multi-state operator (MSO) based in the mid-Atlantic region, for approximately $240 million with the potential for additional performance-based milestone payments. Following the close of two acquisitions that established Columbia Care as a market leader in the two largest cannabis markets in the world, California and Colorado, the acquisition of Green Leaf expands Columbia Care’s operational scale and footprint in four key, limited license markets by materially enhancing the scale and capabilities of its seed-to-sale operations.

Rapid Therapeutic Completes $14M Acquisition of Razor Jacket

/in /by

Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on employing FDA-approved Metered Dose Inhaler (MDI) technology to deliver cannabinoid compounds, such as CBD, CBG, and CBN, announced today that it has closed on a transaction acquiring all of the assets of Razor Jacket, LLC based in Hillsboro, Oregon. The transaction is valued at $14 million in cash and stock which includes all potential future earnouts of $13.2 Million.

TerrAscend Expands U.S. Footprint via Acquisition of Maryland Based Grower Processor

/in /by

TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE:TER,) (OTCQX: TRSSF), a leading North American cannabis operator, announced the signing of a definitive agreement to acquire HMS Health, LLC and HMS Processing, LLC (collectively “HMS”) from Curaleaf Holdings, Inc (“Curaleaf”) (CSE: CURA) (OTCQX: CURLF). HMS is a cultivator and processor of medical cannabis products in the state of Maryland. The acquisition is expected to be immediately accretive to TerrAscend on an EBITDA basis. “This acquisition enables TerrAscend to expand its footprint into another robust limited license medical cannabis market with strong, long-term growth potential,” said Jason Ackerman, Executive Chairman and Chief Executive Officer of TerrAscend.